Rationale: Dopamine D receptor agonists have been shown to improve working memory, but often have a non-monotonic (inverted-U) dose-response curve. One hypothesis is that this may reflect dose-dependent differential engagement of D signaling pathways, a mechanism termed functional selectivity or signaling bias.

Objectives And Methods: To test this hypothesis, we compared two D ligands with different signaling biases in a rodent T-maze alternation task. Both tested ligands (2-methyldihydrexidine and CY208243) have high intrinsic activity at cAMP signaling, but the former also has markedly higher intrinsic activity at D-mediated recruitment of β-arrestin. The spatial working memory was assessed via the alternation behavior in the T-maze where the alternate choice rate quantified the quality of the memory and the duration prior to making a choice represented the decision latency.

Results: Both D drugs changed the alternate rate and the choice latency in a dose-dependent manner, albeit with important differences. 2-Methyldihydrexidine was somewhat less potent but caused a more homogeneous improvement than CY208243 in spatial working memory. The maximum changes in the alternate rate and the choice latency tended to occur at different doses for both drugs.

Conclusions: These data suggest that D signaling bias in these two pathways (cAMP vs β-arrestin) has complex effects on cognitive processes as assessed by T-maze alternation. Understanding these mechanisms should allow the identification or discovery of D agonists that can provide superior cognitive enhancement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693963PMC
http://dx.doi.org/10.1007/s00213-023-06440-5DOI Listing

Publication Analysis

Top Keywords

t-maze alternation
12
working memory
12
intrinsic activity
8
spatial working
8
alternate rate
8
rate choice
8
choice latency
8
signaling
5
characterization behavioral
4
behavioral changes
4

Similar Publications

Paclitaxel (PTX) is a commonly used chemotherapeutic drug, however, one of its major adverse effects is chronic neuropathic pain, with the incidence being higher in women than in men. The neurobiological mechanisms behind this sex difference are still largely unclear, and the endocannabinoid system, which exhibits sexual dimorphism and plays a key role in pain regulation, is a promising area for further studies. The present study aimed to characterise pain-, cognition-, anxiety-, and depression-related behaviours in male and female rats following PTX administration, and associated alterations in the endocannabinoid system.

View Article and Find Full Text PDF

Replay as a Basis for Backpropagation Through Time in the Brain.

Neural Comput

January 2025

Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, U.S.A.

How episodic memories are formed in the brain is a continuing puzzle for the neuroscience community. The brain areas that are critical for episodic learning (e.g.

View Article and Find Full Text PDF

Levo-Stepholidine as a Potential Cognitive Enhancer: Insights into Executive Function and Memory Improvements.

Biomedicines

November 2024

State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai 200032, China.

Background/objectives: Levo-Stepholidine (-SPD), a compound extracted from Chinese herbs, has the potential to treat psychotic disorders where cognitive deficits are a critical challenge. -SPD displays a D1R agonism/D2R antagonism pharmacological profile, and its effect on cognitive function is still vague and lacks comprehensive study. Here, we investigated the impact of l-SPD on two core indexes of executive function, working memory and response inhibition, and learning and memory.

View Article and Find Full Text PDF

Scopolamine animal model of memory impairment.

Behav Brain Res

February 2025

Department of Neurobiology and Biophysics, Institute of Biosciences, Life Sciences Center,  Vilnius University, Lithuania. Electronic address:

Article Synopsis
  • This study evaluates the effectiveness of the scopolamine-induced memory impairment model for Alzheimer's disease by examining behavioral changes associated with the illness, particularly apathy-like behavior.
  • The researchers conducted tests on young male Wistar rats and compared their results with older rats to assess age-related behavior changes.
  • The results indicated that scopolamine treatment increased locomotor activity and impaired object recognition memory, but did not replicate the apathy-like symptoms typically seen in Alzheimer's, showing limitations of this animal model in fully representing the disease.*
View Article and Find Full Text PDF

Baseline-dependent enhancement of working memory by memantine in male rats: Involvement of NMDA receptor subunits and CaMKII signaling.

Pharmacol Biochem Behav

December 2024

Department of Psychology, Asia University, Taichung, Taiwan; Institute of Neuroscience, National Cheng-Chi University, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. Electronic address:

Article Synopsis
  • NMDA receptors, which are activated by glutamate, are essential for learning and memory, and memantine (MEM) is used to manage symptoms in Alzheimer’s but may also have cognitive benefits in healthy individuals.
  • A study on male rats tested MEM's effects on working memory through a T-maze task, finding that MEM improved performance, especially in those with initially poorer memory skills.
  • Neurochemical analysis revealed that certain protein expressions in brain regions were linked to task performance, indicating that the benefits of MEM could depend on an individual’s baseline working memory capability.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!